Motavizumab

Revision as of 20:21, 27 September 2011 by WikiBot (talk | contribs) (Protected "Motavizumab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Drugbox-mab

Motavizumab (proposed INN, trade name Numax) is a humanized monoclonal antibody. It is currently being investigated by MedImmune for the prevention of respiratory syncytial virus infection in high-risk infants.

External links

Template:Humanizedmonoclonals